Autolus Therapeutics (AUTL) Change in Acquisitions & Divestments (2025)

Autolus Therapeutics (AUTL) posted quarterly Change in Acquisitions & Divestments of $126.0 million for Q4 2025, down 3.77% on a QoQ basis from $131.0 million in Q3 2025.

Autolus Therapeutics (AUTL) Change in Acquisitions & Divestments (2025) Analysis & Trends

Autolus Therapeutics (AUTL) has reported Change in Acquisitions & Divestments for 1 consecutive years, with $126.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $126.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $428.2 million (changed N/A YoY) and the FY2025 annual result came in at $428.2 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments retreated to $126.0 million in Q4 2025 per AUTL's latest filing, from $131.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for AUTL reached as high as $151.2 million in Q2 2025 and fell as low as $20.0 million in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,200.25 Bn 66,199.96 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.75 Bn 466.96 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn
7 Belite Bio 62.43 Bn 62.43 Bn -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Autolus Therapeutics 395.22 Mn 94.51 Mn -1.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 126.04 Mn
Dec 31, 2025 126.04 Mn
Sep 30, 2025 130.98 Mn
Sep 30, 2025 130.98 Mn
Jun 30, 2025 151.19 Mn
Jun 30, 2025 151.19 Mn
Mar 31, 2025 20.00 Mn
Mar 31, 2025 20.00 Mn